An error occured. Details Hide
You have unsaved pages. Restore Cancel

The johnson & johnson diluted eps

1.39 US dollars in 1st quarter 2019

Though the johnson & johnson diluted eps fluctuated substantially in recent years, it tended to decrease through 2014 - 2019 period ending at 1.39 US dollars in 1st quarter 2019.

The description is composed by our digital data assistant.
Date Value Change, %
2019Q1 1.39 24.11 %
2018Q4 1.12 -22.22 %
2018Q3 1.44 -0.69 %
2018Q2 1.45 -9.38 %
2018Q1 1.60 -140.20 %
2017Q4 -3.98 -390.51 %
2017Q3 1.37 -2.14 %
2017Q2 1.40 -13.04 %
2017Q1 1.61 16.67 %
2016Q4 1.38 -9.80 %
2016Q3 1.53 6.99 %
2016Q2 1.43
Basic EPS 1.41 US dollars in 1st quarter 2019 ADVFN
Cost of Sales with Depreciation 6,615 millions of US Dollars in 1st quarter 2019 ADVFN
Depreciation millions of US Dollars in 1st quarter 2019 ADVFN
DPS 0.9 US dollars in 1st quarter 2019 ADVFN
EBIT 4,524 millions of US Dollars in 1st quarter 2019 ADVFN
EBITDA 6,285 millions of US Dollars in 1st quarter 2019 ADVFN
Net Income 3,749 millions of US Dollars in 1st quarter 2019 ADVFN
Operating Income 4,439 millions of US Dollars in 1st quarter 2019 ADVFN
Operating Profit after Depreciation 6,285 millions of US Dollars in 1st quarter 2019 ADVFN
Pre-Tax Income 4,422 millions of US Dollars in 1st quarter 2019 ADVFN
Revenue 20,021 millions of US Dollars in 1st quarter 2019 ADVFN
Pfizer 0.68 US dollars in 1st quarter 2019 ADVFN

Our Privacy Statement & Cookie Policy

Our website uses cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your personal cookie settings through your internet browser settings.

Privacy Policy